Brief: Headsent Enters Into Conditional Agreement On Reverse Acquisition Of Vimab Holding

VIMAB AB (publ)

31/05/2022 07:50

May 31 (Reuters) - Headsent AB (publ)  HEADS.ST :
    * HAS ENTERED INTO A CONDITIONAL AGREEMENT ON THE REVERSE
ACQUISITION OF VIMAB HOLDING AB
    * THE PURCHASE PRICE AMOUNTS TO SEK 150 MILLION AND WILL
PAID
THROUGH 16,681,543 SHARES IN HEADSENT
    * THE SELLERS WILL BECOME THE MAJORITY OWNER OF HEADSENT
THROUGH A
REVERSE ACQUISITION
    * HEADSENT WILL CHANGE NAME TO VIMAB GROUP AB
    * THE ACQUISITION IS, AMONG OTHER THINGS, CONDITIONAL ON
HEADSENT
SHAREHOLDER APPROVAL AND APPROVAL BY NASDAQ STOCKHOLM
    * VIMAB GENERATED NET SALES OF SEK 203.2 MILLION WITH AN
OPERATING
PROFIT OF SEK -23.2 MILLION DURING THE FINANCIAL YEAR 2021
    * TRANSACTION AND THE REVIEW PROCESS ARE EXPECTED TO BE
COMPLETED
DURING THIRD QUARTER 2022

Source text for Eikon:  ID:nBQN5z608H 
Further company coverage:  HEADS.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))